EC clears Perrigo's GSK transaction; Australian experts want Hospira's Remicade biosim covered;

@FiercePharma: Beef producers lash out at USDA's choice of Humane Society vet for advisory panel. FierceAnimalHealth article | Follow @FiercePharma

@EricPFierce: Mylan recalls more of the cancer meds made at Indian plants hit with FDA warning letter. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Purdue hones abuse-deterrent edge with painkiller safety campaign. FiercePharmaMarketing story | Follow @CarlyHFierce

> The European Commission (EC) has cleared Perrigo's ($PRGO) acquisition of certain products--such as cold and flu drugs and pain treatments--from GlaxoSmithKline ($GSK). Report

> The European Medicines Agency (EMA) has validated Pfizer's ($PFE) application to market breast cancer treatment Ibrance, clearing the final hurdle before an actual review. More

> A committee of experts in Australia has recommended that Hospira's ($HSP) Remicade biosimilar Inflectra be added to the country's pharmaceutical benefits program. Release

> U.K. cancer patients are missing out on targeted oncology therapies because of failings in the NHS' diagnostic services, a new report says. More

> Anti-infectives maker Xellia has moved its North American headquarters to a Raleigh, NC, plant it bought from Fresenius Kabi last summer. Report

Medical Device News

@FierceMedDev: IYCMI yesterday: Startup nabs $5.3M to back 2015 launch for connected fertility thermometer, app. Article | Follow @FierceMedDev

@VarunSaxena2: Cannabics Pharma's extended-release medical marijuana capsules available in Colorado. FierceDrugDelivery story | Follow @VarunSaxena2

@EmilyWFierce: Lilly faces patent-infringement fight over 'Take-n-Slide' drug adherence tool. More from FiercePharma | Follow @EmilyWFierce

> Gauss raises $3.3M for real-time surgical blood loss monitoring system, iPad app. More

> Patient monitoring company expanding in Milwaukee, adding 150 jobs. Article

Biotech News

@FierceBiotech: Baxalta bets on 'external innovation' to meet its $8.5B goal and ward off Shire. Article | Follow @FierceBiotech

@JohnCFierce: In a first for diabetes, Lilly and Boehringer's Jardiance prevents heart attacks, strokes in trial. FiercePharma story | Follow @JohnCFierce

@DamianFierce: Turing has a new Form D reflecting that $90M claim but now including warrants and a loan. SEC form | Follow @DamianFierce

> 23andMe brings on Dean Schorno as CFO, operations head. Chutes and Ladders

> Takeda rolls toward EU approval with its heir to Velcade. Article

> Raptor buys into cystic fibrosis with a $418M deal. Item

And Finally... Jimmy Carter--who is taking Merck's ($MRK) Keytruda to treat melanoma that has metastasized to the brain--may benefit from new advances in immuno-oncology. More